$JBS

Cavalcanti Guilherme Perboyre sold $2.5M of JBS

Cavalcanti Guilherme Perboyre (Global CFO and IRO) sold 183,501 shares of JBS N.V. (JBS) at $13.85 ($2.54M total) on 2026-08-24.

Original reporting
SEC EDGAR · Cavalcanti Guilherme Perboyre
Published Aug 25, 2026, 3:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 25, 2026, 3:44 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$JBS
Bearish
medium confidence
Mentioned
$JBS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$JBSBearishMed
01

Why it matters

The CFO's complete exit may affect investor sentiment and short-term price action.

02

Market read

Insider sell of this magnitude is material for JBS shareholders and may trigger trading activity.

03

What to watch

Potential tax planning or personal financial needs; no disclosed negative company news.

Relevance 6/10Novelty 7/10Timing: post-market 2026-08-24

Background

Form 4 filings provide the first public disclosure of insider transactions.

Company-level read

Ticker impact

$JBSBearishMedium confidence
Context

CFO and IRO sold 183,501 shares for $2.54M, reducing his stake to zero.

Expected impact

Possible short-term downside pressure; watch for further insider activity.

Evidence & confidence

CFO-level insider exiting completely is material; market may interpret as lack of confidence.

Market effects

May raise concerns for the meat processing sector if other executives follow suit.

Limited to markets where JBS trades; no broader regional effect.

Low global impact; primarily relevant to investors in JBS.

Counterpoint

Insider sell could be routine liquidity event, not necessarily bearish.

Key entities

  • Cavalcanti Guilherme Perboyre

    Global CFO and IRO of JBS N.V.

  • JBS N.V.

    Global meat processing company.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$JBSMed

EU suspends Brazilian poultry and beef imports over antimicrobial compliance

The EU suspended imports of Brazilian poultry, beef, eggs, honey, and other animal products due to non-compliance with antimicrobial rules. The suspension, effective September 3, 2026, impacts major exporters like JBS and Minerva, with Brazil losing access to a market worth USD 1.8 billion annually. The EU cites Brazil's inability to prove compliance, while Brazil argues the move is protectionist. The UK is assessing the situation separately.

$JBSHighAI 9/10

JBS launches fresh bid for full control of Pilgrim’s Pride

JBS, controlling 82% of Pilgrim’s Pride (PPC), proposed a non-binding offer to buy the remaining 18% shares. The deal, valued at $28.49 per share, requires approval from PPC’s board and shareholders. If completed, PPC would delist from Nasdaq. JBS cited PPC’s growth and global presence as reasons for the bid.

$TSNMed

Trump Eases Meat Processing Rules for Ranchers

President Trump proposed regulatory changes to empower ranchers to process their own meat, aiming to challenge the dominance of large meatpacking firms. The move, announced on social media, follows record beef prices and USDA data showing four firms control 85% of cattle procurement. Tyson Foods and JBS shares fell over 2.5% in premarket trading. The USDA also allocated $500 million in aid for smaller beef producers. The policy aims to increase competition and potentially lower beef prices, with